Table 2:
Glucocorticoid dosing (mg/day, prednisolone equivalent) with rituximab- or cyclophosphamide-based regimens for remission induction according to the PEXIVAS study [16].
Week | <50 kg | 50–75 kg | >75 kg |
---|---|---|---|
1 | 50 | 60 | 75 |
2 | 25 | 30 | 40 |
3–4 | 20 | 25 | 30 |
5–6 | 15 | 20 | 25 |
7–8 | 12.5 | 15 | 20 |
9–10 | 10 | 12.5 | 15 |
11–12 | 7.5 | 10 | 12.5 |
13–14 | 6 | 7.5 | 10 |
15–18 | 5 | 5 | 7.5 |
19–52 | 5 | 5 | 5 |
>52 | Individual taper | Individual taper | Individual taper |